Barclays PLC Medtronic PLC Transaction History

Barclays PLC

$288 Billion
Q1 2024

A detailed history of Barclays PLC transactions in Medtronic PLC stock. As of the latest transaction made, Barclays PLC holds 3,726,037 shares of MDT stock, worth $303 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

3,726,037

Previous 98,600 3678.94%

Holding current value

$303 Million

Previous $8.12 Million 3897.57%

% of portfolio

0.11%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$82.84 - $88.09 $17.5 Million - $18.7 Million	211,726 Added 6.02%	3,726,037 $325 Million
Q4 2023 Feb 15, 2024	BUY	$69.43 - $83.43 $4.5 Million - $5.41 Million	64,811 Added 1.88%	3,514,311 $290 Million
Q3 2023 Nov 07, 2023	BUY	$78.22 - $90.4 $40.7 Million - $47.1 Million	520,705 Added 17.78%	3,449,500 $270 Million
Q2 2023 Aug 03, 2023	BUY	$79.47 - $91.38 $103 Million - $118 Million	1,296,065 Added 79.38%	2,928,795 $258 Million
Q1 2023 May 04, 2023	SELL	$76.72 - $87.58 $321 Million - $367 Million	-4,186,727 Reduced 71.94%	1,632,730 $132 Million

Q4 2022 Feb 13, 2023	SELL	$76.18 - $87.74 $97.4 Million - $112 Million	-1,277,920 Reduced 18.01%	5,819,457 $452 Million
Q3 2022 Nov 03, 2022	SELL	$80.75 - $95.31 $241 Million - $284 Million	-2,980,474 Reduced 29.57%	7,097,377 $573 Million
Q2 2022 Aug 12, 2022	BUY	$87.4 - $113.09 $373 Million - $483 Million	4,270,657 Added 73.54%	10,077,851 $904 Million
Q1 2022 May 16, 2022	SELL	$100.58 - $112.38 $78.6 Million - $87.8 Million	-781,700 Reduced 11.86%	5,807,194 $644 Million
Q4 2021 Feb 14, 2022	BUY	$99.53 - $127.75 $193 Million - $247 Million	1,937,158 Added 41.64%	6,588,894 $682 Million
Q3 2021 Nov 09, 2021	BUY	$122.75 - $135.17 $97.8 Million - $108 Million	796,827 Added 20.67%	4,651,736 $583 Million
Q2 2021 Aug 13, 2021	BUY	$118.19 - $131.5 $52.7 Million - $58.6 Million	445,618 Added 13.07%	3,854,909 $479 Million
Q1 2021 May 13, 2021	BUY	$111.18 - $119.74 $44.6 Million - $48 Million	401,049 Added 13.33%	3,409,291 $403 Million
Q4 2020 Feb 11, 2021	SELL	$100.57 - $117.14 $61.8 Million - $72 Million	-614,745 Reduced 16.97%	3,008,242 $352 Million
Q3 2020 Nov 12, 2020	BUY	$90.13 - $108.78 $106 Million - $128 Million	1,178,976 Added 48.24%	3,622,987 $377 Million
Q2 2020 Aug 12, 2020	BUY	$84.11 - $103.33 $9.47 Million - $11.6 Million	112,626 Added 4.83%	2,444,011 $224 Million
Q1 2020 May 13, 2020	SELL	$72.92 - $121.3 $50.4 Million - $83.9 Million	-691,405 Reduced 22.87%	2,331,385 $210 Million
Q4 2019 Feb 10, 2020	SELL	$104.49 - $114.54 $8.06 Million - $8.84 Million	-77,166 Reduced 2.49%	3,022,790 $343 Million
Q3 2019 Nov 14, 2019	SELL	$98.02 - $111.18 $82.4 Million - $93.5 Million	-840,657 Reduced 21.33%	3,099,956 $337 Million
Q2 2019 Aug 14, 2019	BUY	$84.15 - $99.38 $66.6 Million - $78.7 Million	791,537 Added 25.14%	3,940,613 $384 Million
Q1 2019 May 15, 2019	SELL	$82.45 - $93.79 $3.59 Million - $4.08 Million	-43,523 Reduced 1.36%	3,149,076 $287 Million
Q4 2018 Feb 14, 2019	SELL	$85.8 - $99.49 $13.1 Million - $15.2 Million	-153,097 Reduced 4.58%	3,192,599 $290 Million
Q3 2018 Nov 14, 2018	SELL	$85.91 - $99.17 $14.4 Million - $16.6 Million	-167,559 Reduced 4.77%	3,345,696 $329 Million
Q2 2018 Aug 14, 2018	SELL	$77.48 - $87.83 $78 Million - $88.4 Million	-1,006,959 Reduced 22.28%	3,513,255 $301 Million
Q1 2018 May 15, 2018	BUY	$76.55 - $87.26 $65.5 Million - $74.6 Million	855,053 Added 23.33%	4,520,214 $363 Million
Q4 2017 Feb 14, 2018	BUY	$76.93 - $83.5 $103 Million - $111 Million	1,334,397 Added 57.25%	3,665,161 $296 Million
Q3 2017 Nov 14, 2017	BUY	$77.71 - $84.6 $181 Million - $197 Million	2,330,764	2,330,764 $181 Million

Others Institutions Holding MDT

# of Institutions

2,230

Shares Held

1.05B

Call Options Held

6.1M

Put Options Held

7.84M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $108B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account